FCN2 and lobular neoplasia: A study by Elkoumi et al. in patients with pediatric-onset SLE (pSLE) reported that FCN2 promoter region polymorphisms may influence pSLE susceptibility, where rs3124952 and rs17514136 were significantly associated with increased risk of LN.14